These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18997495)

  • 1. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.
    Giustina A; Barkan A; Chanson P; Grossman A; Hoffman A; Ghigo E; Casanueva F; Colao A; Lamberts S; Sheppard M; Melmed S; ;
    J Endocrinol Invest; 2008 Sep; 31(9):820-38. PubMed ID: 18997495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess.
    Ciresi A; Giordano C
    Growth Horm IGF Res; 2017 Apr; 33():35-42. PubMed ID: 28372721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making a rational diagnosis of growth-hormone deficiency.
    Preece MA
    J Pediatr; 1997 Jul; 131(1 Pt 2):S61-4. PubMed ID: 9255231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Acromegaly and Growth Hormone Action.
    Maffezzoni F; Porcelli T; Delbarba A; Pezzaioli L; Cappelli C; Ferlin A
    Protein Pept Lett; 2020; 27(12):1231-1245. PubMed ID: 32310036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment.
    Brabant G
    Eur J Endocrinol; 2003 Apr; 148 Suppl 2():S15-20. PubMed ID: 12670296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal.
    Gibney J; Johannsson G
    Horm Res; 2004; 62 Suppl 1():66-72. PubMed ID: 15761235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen JO; Sandahl Christiansen J; Orskov H
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):25-33. PubMed ID: 10651750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in the diagnosis of GH deficiency (GHD) during childhood.
    Hasegawa Y; Hasegawa T; Anzo M; Aso T; Tsuchiya Y
    Endocr J; 1996 Oct; 43 Suppl():S1-4. PubMed ID: 9076335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.
    Roelen CA; Koppeschaar HP; de Vries WR; Doerga ME; Snel YE; Bol E; Zelissen PM; Thijssen JH; Blankenstein MA
    Metabolism; 1999 Mar; 48(3):314-8. PubMed ID: 10094106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and risk for cardiac tumors in Carney complex.
    Bandettini WP; Karageorgiadis AS; Sinaii N; Rosing DR; Sachdev V; Schernthaner-Reiter MH; Gourgari E; Papadakis GZ; Keil MF; Lyssikatos C; Carney JA; Arai AE; Lodish M; Stratakis CA
    Endocr Relat Cancer; 2016 Sep; 23(9):739-46. PubMed ID: 27535175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Fukuda I; Hizuka N; Itoh E; Yasumoto K; Ishikawa Y; Murakami Y; Sata A; Takano K
    Endocr J; 2002 Jun; 49(3):379-86. PubMed ID: 12201224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene.
    Schmid C; Krayenbuehl PA; Bernays RL; Zwimpfer C; Maly FE; Wiesli P
    Clin Chem; 2007 Aug; 53(8):1484-8. PubMed ID: 17573420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acromegaly, growth hormone and cancer risk.
    Renehan AG; Brennan BM
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion.
    Albertsson-Wikland K; Kriström B; Lundberg E; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Horm Res Paediatr; 2014; 82(3):158-70. PubMed ID: 25170833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed levels of growth hormone and insulin-like growth factor-1 during successful pregnancy in persistent acromegaly.
    Shimatsu A; Usui T; Tagami T; Kuzuya H; Takahashi JA
    Endocr J; 2010; 57(6):551-3. PubMed ID: 20371983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.